Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 160,000 shares at $173.30 ($27.8M) on 2023-02-16, disclosed to the SEC on 2023-02-17.
Seasonal sale ($27.8M) by Chief Executive Officer — this insider has traded MRNA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $173.68 | 10,327 | $1.8M | 6.4% |
| 2 | $173.68 | 10,327 | $1.8M | 6.4% |
| 3 | $174.77 | 13,375 | $2.3M | 8.4% |
| 4 | $174.77 | 13,375 | $2.3M | 8.4% |
| 5 | $175.85 | 14,812 | $2.6M | 9.4% |
| 6 | $175.85 | 14,812 |
| $2.6M |
| 9.4% |
| 7 | $176.73 | 1,486 | $263K | 0.9% |
| 8 | $176.73 | 1,486 | $263K | 0.9% |
| 9 | $172.14 | 8,952 | $1.5M | 5.5% |
| 10 | $172.14 | 8,952 | $1.5M | 5.5% |
| 11 | $173.30 | 28,331 | $4.9M | 17.6% |
| 12 | $173.30 | 28,331 | $4.9M | 17.6% |
| 13 | $173.79 | 2,717 | $472K | 1.7% |
| 14 | $173.79 | 2,717 | $472K | 1.7% |
| Total | $174.02 avg | 160,000 | $27.8M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |